GSK Expands Licensing Agreement for GeneGo’s Informatics Tools | GenomeWeb
NEW YORK (GenomeWeb News) – GeneGo said today that GlaxoSmithKline has extended a licensing agreement for its systems biology software tools.
The expanded agreement provides GSK’s researchers in bioinformatics, R&D, and clinical studies with global access to GeneGo’s MetaCore, MapEditor, and MetaBase informatics tools.
GSK will use MetaCore, a collection of pathway maps and network models, as “a repository of all types of experimental data as well as resulting analyses,” GeneGo said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.